Scientists probe hidden heart effects of popular Weight-Loss drugs
NCT ID NCT07483801
First seen Mar 25, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study looks at how two diabetes and weight-loss drugs, semaglutide and tirzepatide, affect blood vessels and heart function directly—not just through weight loss. Researchers will give the drugs to 112 adults with different body weights and blood pressure levels, then measure changes in blood flow and heart activity. The goal is to understand if these drugs have extra benefits for the heart and circulation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Addenbrooke's Hospital
Cambridge, Cambridgeshire, CB20QQ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.